Basf Aktiengesellschaft

Peter Scharwaechter

Klaus Gutsche

Wilhelm Kohlmann

Friedrich-Wilhelm Kohlmann

By Norma Kroemer, Legal Representative

By Maria Kroemer, Legal Representative

By Helmut Kroemer, Legal Representative

Bernd Janssen

Horst Koenig

Gerd Kroemer

Gerd Kroemer, Deceased

Hinrich Beck

Gerhard Kroemer, Deceased

Viral diseases are treated by a method in which an effective amount of 1-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)ethan-1-ol (formula I) ##STR1## is administered enterally, parenterally or topically to a patient suffering therefrom.

Treatment of viral diseases

2-Carbamic acid esters of 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine (trimethoprim), a process for their preparation, and drugs containing these compounds, which, as pro-drugs of trimethoprim, have valuable antibacterial properties and potentiate the antibacterial action of sulfonamides.

N-Pyrimidinyl-carbamic acid esters, their preparation, and drugs

5-Benzyl-4-amino-pyrimidine-2-amidines which may or may not be substituted in the phenyl ring, and their physiologically acceptable addition salts with acids, processes for their preparation, drugs containing these compounds, and their use in infectious diseases.

Novel amidino-benzylpyrimidines, processes for their manufacture and

Unsubstituted or substituted 5-phenyl- and 5-benzyl-4-amino-pyrimidine-2-imidoacid esters, their preparation, drugs containing these compounds, and their use in infectious diseases.

N-Pyrimidinyl-imidoacid esters and drugs containing the said compounds

5-Benzyl-2,4-diaminopyrimidines, in which the 2-amino group is substituted, and which may or may not be substituted in the phenyl ring, and their physiologically acceptable addition salts with acids, processes for their manufacture, drugs containing these compounds, and the use of the said compounds in infectious diseases.

Benzylpyrimidines, processes for their manufacture, and drugs containing

2-Acylamino-4-amino-5-benzylpyrimidines substituted in the phenyl ring of the benzyl radical, their production and their use as sulfonamide potentiators, as well as agents containing the same, are disclosed. The compounds 4-amino-2-formamido-5-(3,4,5-trimethoxybenzyl)-pyrimidine and 4-amino-2-acetamido-5-(3,4,5-trimethoxybenzyl)-pyrimidine are examples of the subject pyrimidines.

Growing community of inventors

Moorrege, Germany

Peter Scharwaechter